IndraLab

Statements

Ponatinib inhibits KCNH2. 1 / 1

| 1

reach

"71 The exception seems to be ponatinib, which inhibited hERG at concentrations above 1muM, substantially in excess of the steady-state maximal concentrations observed in patients treated at the clinical dose of 45mg."

27121688

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Ponatinib inhibits KCNH2. 1 / 1

INDRA sources:

Databases

Reading